Cargando…

Cannabidiol in Parkinson’s disease

Detalles Bibliográficos
Autor principal:	Rieder, Carlos R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115444/ https://www.ncbi.nlm.nih.gov/pubmed/32187321 http://dx.doi.org/10.1590/1516-4446-2019-0810

Ejemplares similares

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
por: Ferreira-Junior, Nilson C., et al.
Publicado: (2019)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Cannabidiol and Tetrahydrocannabinol Use in Parkinson’s Disease: An Observational Pilot Study
por: Sousa, Amber, et al.
Publicado: (2023)

Parasitic pharmacology: A plausible mechanism of action for cannabidiol
por: Groeneveld, Geert Jan, et al.
Publicado: (2019)

Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment
por: Kessler, Felix H., et al.
Publicado: (2021)

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
por: Patricio, Felipe, et al.
Publicado: (2020)

Inflammation and Parkinson's Disease
por: Barcia, Carlos, et al.
Publicado: (2011)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis
por: Zhao, Jinchuan, et al.
Publicado: (2022)

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol
por: Storozhuk, Maksim V.
Publicado: (2023)

Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation
por: Vallée, Alexandre, et al.
Publicado: (2021)

Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke
por: Meyer, Erika, et al.
Publicado: (2022)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Cannabidiol and Other Cannabinoids in Demyelinating Diseases
por: Navarrete, Carmen, et al.
Publicado: (2021)

Assessment of Nonverbal and Verbal Apraxia in Patients with Parkinson's Disease
por: Presotto, Monia, et al.
Publicado: (2015)

Rehabilitation and Parkinson's Disease
por: Earhart, Gammon M., et al.
Publicado: (2012)

Neuropsychiatry of Parkinson's Disease
por: Teixeira, Antonio L., et al.
Publicado: (2012)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Gait in Parkinson's Disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2019)

Neurobiology of Parkinson’s Disease
por: Morelli, Micaela, et al.
Publicado: (2023)

Tremor of the Eyes, or of the Head, in Parkinson's Disease?
por: Leigh, R John, et al.
Publicado: (2013)

Did depressive symptoms affect recognition of emotional prosody in Parkinson’s disease?
por: Vélez Feijó, Adriana, et al.
Publicado: (2008)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile
por: Akinyemi, Rufus O
Publicado: (2012)

Neurobiology Research in Parkinson’s Disease
por: Yasuhara, Takao
Publicado: (2020)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Communication Impairments in Parkinson's Disease
por: Murdoch, Bruce, et al.
Publicado: (2011)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Implication of Autophagy in Parkinson's Disease
por: González-Polo, Rosa Ana, et al.
Publicado: (2013)

Rehabilitation and Parkinson's Disease 2013
por: Earhart, Gammon M., et al.
Publicado: (2013)

Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

The sweet road to Parkinson’s disease
por: Renaud, Justine, et al.
Publicado: (2019)

Nonmotor Symptoms of Parkinson's Disease
por: Wu, Shey-Lin, et al.
Publicado: (2017)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Advances in Parkinson’s Disease Drugs
por: Di Stefano, Antonio, et al.
Publicado: (2021)

Optimizing Treatment of Parkinson’s Disease
por: Nyholm, Dag, et al.
Publicado: (2022)

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
por: Caillava-Santos, Fabiane, et al.
Publicado: (2015)

The Journal of Parkinson’s Disease Takes the Open Road
por: Bloem, Bastiaan R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sk35ub58h988or19t8thlapgbg